Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells

Glycogen synthase kinase-3 (GSK-3), an enzyme that modulates glucose metabolism, has been recognized as an essential target in major inflammatory diseases based on its great specificity in substrate recognition. GSK-3β has been connected to cancer, obesity, liver diseases, and neurological diseases....

Full description

Saved in:
Bibliographic Details
Main Author: Oyewole, Oluwaseyi
Format: Thesis
Published: AUC Knowledge Fountain 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613424184197120
access_status_str Open Access
author Oyewole, Oluwaseyi
author_browse Oyewole, Oluwaseyi
author_facet Oyewole, Oluwaseyi
author_sort Oyewole, Oluwaseyi
collection Thesis
description Glycogen synthase kinase-3 (GSK-3), an enzyme that modulates glucose metabolism, has been recognized as an essential target in major inflammatory diseases based on its great specificity in substrate recognition. GSK-3β has been connected to cancer, obesity, liver diseases, and neurological diseases. Nonetheless, the other GSK-3 isoform, GSK-3α, is much less studied. Previous studies from our laboratory showed that inhibiting GSK-3α potentially confers an anti-inflammatory response when tested on microglia. However, little has been documented regarding the exact mechanism by which GSK-3α exerts its effect. One of the potential mechanisms involving its anti-inflammatory effect could be partially attributed to activating the nuclear factor erythroid 2–related factor 2 (Nrf2) signaling pathway. This study examines whether the inhibition of GSK-3α confers an anti-inflammatory and antioxidant response independent of the Nrf2 pathway. Our result showed that inhibiting GSK-3α in LPS-stimulated RAW 264.7 cells downregulate nitrate production. Real-time PCR results indicated that inhibiting GSK-3α in LPS-stimulated macrophages attenuates the expression of the proinflammatory genes Tumor necrosis factor (TNF-α), inducible nitric oxide synthase (iNOS), and interleukin 6 (IL-6). Remarkably, at the translation level, the protein expression levels of iNOS and TNF-α were also denounced. Interestingly, our study provides further insight into the anti-inflammatory role of GSK-3α in post-transcriptional studies as evidenced in the downregulation of two mRNAs, in particular, miR-21 and miR-155, implicated in inflammatory-related diseases post GSK-3α inhibition. Our molecular assay showed that the Nrf2-regulated genes: Osgin1 (Oxidative Stress Induced Growth Inhibitor 1) and HO-1(Heme oxygenase-1) were upregulated in response to treatment with GSK-3α inhibitor when compared to their control counterparts. Collectively, our results indicate the role of GSK-3α in modulating inflammatory responses and suggest Nrf2 as a possible pathway that mediate the anti-inflammatory and antioxidant benefits of GSK-3α inhibition.
format Thesis
id oai:fount.aucegypt.edu:etds-3429
institution American University in Cairo (Egypt)
last_indexed 2026-06-10T12:35:55.364Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from AUC Knowledge Fountain — bepress
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher AUC Knowledge Fountain
publisherStr AUC Knowledge Fountain
record_format dspace
source_str AUC Knowledge Fountain — bepress
spelling oai:fount.aucegypt.edu:etds-3429 The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells Oyewole, Oluwaseyi Glycogen synthase kinase-3 (GSK-3), an enzyme that modulates glucose metabolism, has been recognized as an essential target in major inflammatory diseases based on its great specificity in substrate recognition. GSK-3β has been connected to cancer, obesity, liver diseases, and neurological diseases. Nonetheless, the other GSK-3 isoform, GSK-3α, is much less studied. Previous studies from our laboratory showed that inhibiting GSK-3α potentially confers an anti-inflammatory response when tested on microglia. However, little has been documented regarding the exact mechanism by which GSK-3α exerts its effect. One of the potential mechanisms involving its anti-inflammatory effect could be partially attributed to activating the nuclear factor erythroid 2–related factor 2 (Nrf2) signaling pathway. This study examines whether the inhibition of GSK-3α confers an anti-inflammatory and antioxidant response independent of the Nrf2 pathway. Our result showed that inhibiting GSK-3α in LPS-stimulated RAW 264.7 cells downregulate nitrate production. Real-time PCR results indicated that inhibiting GSK-3α in LPS-stimulated macrophages attenuates the expression of the proinflammatory genes Tumor necrosis factor (TNF-α), inducible nitric oxide synthase (iNOS), and interleukin 6 (IL-6). Remarkably, at the translation level, the protein expression levels of iNOS and TNF-α were also denounced. Interestingly, our study provides further insight into the anti-inflammatory role of GSK-3α in post-transcriptional studies as evidenced in the downregulation of two mRNAs, in particular, miR-21 and miR-155, implicated in inflammatory-related diseases post GSK-3α inhibition. Our molecular assay showed that the Nrf2-regulated genes: Osgin1 (Oxidative Stress Induced Growth Inhibitor 1) and HO-1(Heme oxygenase-1) were upregulated in response to treatment with GSK-3α inhibitor when compared to their control counterparts. Collectively, our results indicate the role of GSK-3α in modulating inflammatory responses and suggest Nrf2 as a possible pathway that mediate the anti-inflammatory and antioxidant benefits of GSK-3α inhibition. 2025-01-31T08:00:00Z thesis application/pdf https://fount.aucegypt.edu/etds/2385 https://fount.aucegypt.edu/context/etds/article/3429/viewcontent/oluwaseyi_seun_oyewole_thesis.pdf Theses and Dissertations AUC Knowledge Fountain Inflammation Glycogen synthase kinase-3 Nrf2 Oxidative stress Inflammatory responses Biotechnology Immunity Other Life Sciences
spellingShingle Inflammation
Glycogen synthase kinase-3
Nrf2
Oxidative stress
Inflammatory responses
Biotechnology
Immunity
Other Life Sciences
Oyewole, Oluwaseyi
The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title_full The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title_fullStr The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title_full_unstemmed The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title_short The Role of GSK-3α Inhibition in Attenuating LPS-Induced Inflammation in RAW 264.7 Cells
title_sort role of gsk 3α inhibition in attenuating lps induced inflammation in raw 264 7 cells
topic Inflammation
Glycogen synthase kinase-3
Nrf2
Oxidative stress
Inflammatory responses
Biotechnology
Immunity
Other Life Sciences
url https://fount.aucegypt.edu/etds/2385
https://fount.aucegypt.edu/context/etds/article/3429/viewcontent/oluwaseyi_seun_oyewole_thesis.pdf
work_keys_str_mv AT oyewoleoluwaseyi theroleofgsk3ainhibitioninattenuatinglpsinducedinflammationinraw2647cells
AT oyewoleoluwaseyi roleofgsk3ainhibitioninattenuatinglpsinducedinflammationinraw2647cells